Back

Insights from the first trials in epigenetics in human: what is the way forward?

26 August 2017 (16:05 - 16:25)
Organised by:
Congress Presentation Part of: Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited) Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail
Introduction - Managing diabetes & CVD: is epigenetics a new way forward?
Professor L. Badimon (Barcelona, ES)
Presentation thumbnail
Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?
Professor R. Kausik
Presentation thumbnail
Promise of epigenetic modulation as a target in atherosclerotic patients.
Professor E. Stroes (Amsterdam, NL)
Presentation thumbnail
Discussion - Managing diabetes & CVD: is epigenetics a new way forward?
Professor R. Kausik

Access the full session

Session thumbnail
Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

The Event

Event poster

ESC Congress 2017

26 August 2017 16:05 CET
You may be interested in
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
17 May 2025
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Session
Latest science in pharmacotherapy
29 August 2022
thumbnail
Congress Session
The ESC Journal Family: focus on personalised care in different fields of cardiovascular medicine
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources